OpenURL Connection Search

Select item for more details and to access through your institution.

Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial‐encoded mRNAs.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 6, p. 775, doi. 10.1016/j.jalz.2017.12.005
By:
- Mastroeni, Diego;
- Nolz, Jennifer;
- Khdour, Omar M.;
- Sekar, Shobana;
- Delvaux, Elaine;
- Cuyugan, Lori;
- Liang, Winnie S.;
- Hecht, Sidney M.;
- Coleman, Paul D.
Publication type:
Article
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
Published in:
Investigational New Drugs, 2019, v. 37, n. 4, p. 636, doi. 10.1007/s10637-018-0668-8
By:
- Babiker, Hani M.;
- Byron, Sara A.;
- Hendricks, William P. D.;
- Elmquist, William F.;
- Gampa, Gautham;
- Vondrak, Jessica;
- Aldrich, Jessica;
- Cuyugan, Lori;
- Adkins, Jonathan;
- De Luca, Valerie;
- Tibes, Raoul;
- Borad, Mitesh J.;
- Marceau, Katie;
- Myers, Thomas J.;
- Paradiso, Linda J.;
- Liang, Winnie S.;
- Korn, Ronald L.;
- Cridebring, Derek;
- Von Hoff, Daniel D.;
- Carpten, John D.
Publication type:
Article
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.
Published in:
PLoS ONE, 2019, v. 14, n. 12, p. N.PAG, doi. 10.1371/journal.pone.0219724
By:
- Berens, Michael E.;
- Sood, Anup;
- Barnholtz-Sloan, Jill S.;
- Graf, John F.;
- Cho, Sanghee;
- Kim, Seungchan;
- Kiefer, Jeffrey;
- Byron, Sara A.;
- Halperin, Rebecca F.;
- Nasser, Sara;
- Adkins, Jonathan;
- Cuyugan, Lori;
- Devine, Karen;
- Ostrom, Quinn;
- Couce, Marta;
- Wolansky, Leo;
- McDonough, Elizabeth;
- Schyberg, Shannon;
- Dinn, Sean;
- Sloan, Andrew E.
Publication type:
Article
Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects.
Published in:
2018
By:
- Sekar, Shobana;
- Cuyugan, Lori;
- Adkins, Jonathan;
- Geiger, Philipp;
- Liang, Winnie S.
Publication type:
Abstract
Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.
Published in:
Molecular Genetics & Genomic Medicine, 2015, v. 3, n. 2, p. 130, doi. 10.1002/mgg3.121
By:
- Sekulic, Aleksandar;
- Liang, Winnie S.;
- Tembe, Waibhav;
- Izatt, Tyler;
- Kruglyak, Semyon;
- Kiefer, Jeffrey A.;
- Cuyugan, Lori;
- Zismann, Victoria;
- Legendre, Christophe;
- Pittelkow, Mark R.;
- Gohmann, John J.;
- De Castro, Fernando R.;
- Trent, Jeffrey;
- Carpten, John;
- Craig, David W.;
- McDaniel, Timothy K.
Publication type:
Article

Found: 5

Oligomeric amyloid β preferentially targets neuronal and not glial mitochondrial‐encoded mRNAs.

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.

Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.

Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects.

Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.